|
(b)(4).A manufacturing record evaluation was performed for the finished device lot number qbmhsz, and no non-conformance's related to the reported complaint condition were identified.Investigation summary : it was reported that six weeks post op of a hip surgery, the patient had necrotic tissue long the suture line.Two opened boxes with a total of seven-teen unopened samples of product code y497g, lot # qbmhsz were returned for analysis.The complaint sample was not received for evaluation.Thirteen unopened sample was examined for visual defects: appearance, color package, wrinkles in the seal area, continuous seals, seal margins, over-sealing, damage (torn, punctured).The packets were opened, and the swage and attachment area were noted to be as expected.During the visual inspection the sutures were correctly placed on winding former.Sutures were dispensed without problems and examined along of the strand and no defects, damaged on suture or surface could be observed.As part of our quality process, the manufacturing records of this lot-serial number were reviewed, and the manufacturing standards were met prior to the release of this batch.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.The patient demographic info: age, gender, weight, bmi at the time of index procedure date of the index surgical procedure? the diagnosis and indication for the index surgical procedure? what was the onset date of necrosis following the index surgery? did the patient experience an infection? if yes, were cultures performed? results? date the debridement and reapproximation were performed? what was the appearance of the monocryl suture during the second procedure? where and how was the dermabond device used (what layer of tissue and how many layers applied)? was a dressing applied over the dermabond? if yes, please describe, including brand name.How many days post-op was the dressing in place? what was the frequency of dressing changes? has the patient had prior exposure to dermabond, prineo or skin adhesives? lot number of dermabond used.Other relevant patient history / concomitant medications? if applicable, will product be returned? what is the patient¿s current status? note: event related to topical skin adhesive reported via mw# 2210968-2020-07109.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|